The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study

OBJECTIVE: Immune checkpoint inhibitors (ICIs) have been considered as novel therapeutic approaches for various cancers. ICIs were reportedly efficacious against rare cancers, including salivary gland carcinoma (SGC). We aimed to analyze the efficacy and safety of ICIs in patients with SGC. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Ryosuke, Kumai, Takumi, Ishida, Yoshiya, Yuasa, Ryota, Kubota, Akinobu, Wakisaka, Risa, Komatsuda, Hiroki, Yamaki, Hidekiyo, Wada, Tetsuji, Harabuchi, Yasuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Head and Neck, and Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764769/
https://www.ncbi.nlm.nih.gov/pubmed/36544935
http://dx.doi.org/10.1002/lio2.863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764769/
https://www.ncbi.nlm.nih.gov/pubmed/36544935
http://dx.doi.org/10.1002/lio2.863

Ejemplares similares